Medical Management of Chemical Casualties Handbook

Aberdeen Proving Grounds, MD: U. S, Army Medical Research Institute of Chemical Defense (USAMRICD), 2000. Third Edition. Wraps. Good. [4], 290, [8] pages. Fold-out illustration. Tables. Glossary of Terms. Index. Title page has been removed. The purpose of this handbook is to provide medical personnel in the field a concise, pocket-sized reference source for the medical management of chemical casualties. It is not intended to be a definitive text on the management of chemical casualties. The end of World War II did not stop the development, stockpiling, or use of chemical weapons. During the Yemen War of 1963 through 1967, Egypt probably used mustard bombs in support of South Yemen against royalist troops in North Yemen. The U.S., which used defoliants and riot-control agents in Vietnam and Laos, ratified the Geneva Protocol in 1975, but with the stated reservation that the treaty did not apply either to defoliants or riot-control agents. The Soviet Union was accused of using chemical agents in Afghanistan. The United States Army Medical Research Institute of Chemical Defense (USAMRICD) is a military medical research institute located at Aberdeen Proving Ground, Maryland. It is the leading science and technology laboratory of the Department of Defense for the development, testing, and evaluation of medical chemical warfare countermeasures to treat casualties of chemical warfare agents. The mission of USAMRICD includes fundamental and applied research in the pharmacology, physiology, toxicology, pathology, and biochemistry of chemical agents and their medical countermeasures. The Institute, with the United States Army Medical Research Institute of Infectious Diseases, educates health care providers in the medical management of chemical and biological agent casualties. The USAMRICD supports a Chemical/Biological Rapid Response Team (C/B-RRT), supports and trains Area Medical Laboratory personnel, and maintains a chemical surety facility.